These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37277788)

  • 1. The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules.
    Tahvilian S; Kuban JD; Yankelevitz DF; Leventon D; Henschke CI; Zhu J; Baden L; Yip R; Hirsch FR; Reed R; Brown A; Muldoon A; Trejo M; Katchman BA; Donovan MJ; Pagano PC
    BMC Pulm Med; 2023 Jun; 23(1):193. PubMed ID: 37277788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
    Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
    BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Patient With a Pulmonary Nodule: A Review.
    Mazzone PJ; Lam L
    JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision patient selection for improved detection of circulating genetically abnormal cells in pulmonary nodules.
    Tu M; Wang X; Liu H; Jia H; Wang Y; Li J; Zhang G
    Sci Rep; 2024 Sep; 14(1):22532. PubMed ID: 39341939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical validation of the LungLB test: a 4-color fluorescence in-situ hybridization assay for the evaluation of indeterminate pulmonary nodules.
    Lutman ML; Gramajo-Leventon D; Tahvilian S; Baden L; Gilbert CL; Trejo M; Vail E; Donovan MJ; Katchman BA; Pagano PC
    BMC Pulm Med; 2024 Sep; 24(1):475. PubMed ID: 39334110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive early detection of malignant pulmonary nodules by FISH-based sputum test.
    Shlomi D; Peled N; Schwarz YA; Soo Hoo GW; Batra RK; Fink G; Kaplan T; Cohen L; Mollan S; Burfeind WR
    Cancer Genet; 2018 Oct; 226-227():1-10. PubMed ID: 30005848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.
    Peters AA; Weinheimer O; von Stackelberg O; Kroschke J; Piskorski L; Debic M; Schlamp K; Welzel L; Pohl M; Christe A; Ebner L; Kauczor HU; Heußel CP; Wielpütz MO
    Eur Radiol; 2023 Jun; 33(6):3908-3917. PubMed ID: 36538071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive diagnosis of pulmonary nodules by circulating tumor DNA methylation: A prospective multicenter study.
    Li Y; Xie F; Zheng Q; Zhang Y; Li W; Xu M; He Q; Li Y; Sun J
    Lung Cancer; 2024 Sep; 195():107930. PubMed ID: 39146624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced computed tomography for the diagnosis of solitary pulmonary nodules: a systematic review and meta-analysis.
    Weir-McCall JR; Joyce S; Clegg A; MacKay JW; Baxter G; Dendl LM; Rintoul RC; Qureshi NR; Miles K; Gilbert FJ
    Eur Radiol; 2020 Jun; 30(6):3310-3323. PubMed ID: 32060716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
    Wahidi MM; Govert JA; Goudar RK; Gould MK; McCrory DC;
    Chest; 2007 Sep; 132(3 Suppl):94S-107S. PubMed ID: 17873163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy.
    Reid M; Choi HK; Han X; Wang X; Mukhopadhyay S; Kou L; Ahmad U; Wang X; Mazzone PJ
    Chest; 2019 Aug; 156(2):367-375. PubMed ID: 30940455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
    Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating proteome for pulmonary nodule malignancy.
    Khodayari Moez E; Warkentin MT; Brhane Y; Lam S; Field JK; Liu G; Zulueta JJ; Valencia K; Mesa-Guzman M; Nialet AP; Atkar-Khattra S; Davies MPA; Grant B; Murison K; Montuenga LM; Amos CI; Robbins HA; Johansson M; Hung RJ
    J Natl Cancer Inst; 2023 Sep; 115(9):1060-1070. PubMed ID: 37369027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-guided percutaneous coaxial cutting needle biopsy of small pulmonary nodules: feasibility.
    Liu M; Lv Y; Wu L; Song J; Sequeiros RB; Li C
    Eur Radiol; 2013 Oct; 23(10):2730-8. PubMed ID: 23645385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
    Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
    Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.